1. Introduction {#sec1-molecules-22-01825}
===============

The genus *Hosta* belongs to the family Liliaceae, with approximately 40 species distributed in the temperate and subtropical zones of Asia \[[@B1-molecules-22-01825]\]. The ethnopharmacological and chemotaxonomic significance of the genus *Hosta* led us to investigate the chemical constituents of one of its species, namely *Hosta plantaginea* (Lam.) Aschers, which was a medicinal and ornamental plant in China. Its flowers are commonly used as a traditional Mongolian medicine in China for the treatment of sore throat, mute, lung heat, and toxic heat \[[@B2-molecules-22-01825]\]. Previous phytochemical studies on *H. plantaginea* afforded structurally-diverse and biologically-active compounds, such as steroidals, alkaloids, flavonoids, and monoterpenes, some of them showed potent anti-inflammatory, cytotoxic, antibacterial, antiviral, and antioxidant activities \[[@B3-molecules-22-01825],[@B4-molecules-22-01825],[@B5-molecules-22-01825],[@B6-molecules-22-01825],[@B7-molecules-22-01825],[@B8-molecules-22-01825]\]. These facts encouraged us to investigate new and bioactive secondary metabolites from *H. plantaginea*. In the present study, we had isolated and elucidated two new phenolic glucosides (**1** and **2**), and six known ones from the ethanol extract of the flowers of *H. plantaginea*. Herein, we report the isolation, structure elucidation, as well as the cyclooxygenases' (COX-1 and COX-2) inhibition and antioxidant activities of compounds **1**--**8** ([Figure 1](#molecules-22-01825-f001){ref-type="fig"}). This is the first report of compounds **3** and **5**--**8** from the Liliaceae family. The chemotaxonomic significance of the isolated compounds was also summarized.

2. Results and Discussion {#sec2-molecules-22-01825}
=========================

2.1. Identification of Compounds ***1***--***8*** {#sec2dot1-molecules-22-01825}
-------------------------------------------------

Compound **1** was isolated as a yellow oil, $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ −48.2 (*c* 1.0, CH~3~OH), had a molecular formula of C~22~H~24~O~10~ on the basis of the HR-ESI-MS (*m*/*z* 449.14498, calcd. 449.14422 \[M + H\]^+^). The UV absorption bands at λ~max~ 281 and 322 nm suggested the presence of a flavanone skeleton in **1** \[[@B9-molecules-22-01825]\]. The ^1^H-NMR spectrum of **1** ([Table 1](#molecules-22-01825-t001){ref-type="table"}, see the [Supplementary Materials](#app1-molecules-22-01825){ref-type="app"}) exhibited a pair of meta-positioned aromatic protons at *δ*~H~ 6.28 and 6.24 (each, 1H, d, *J* = 2.5 Hz) in ring A, an AA'XX' coupling system at *δ*~H~ 7.30 and 6.79 (each, 2H, d, *J* = 8.4 Hz) in ring B. The ^13^C-NMR spectrum of **1** ([Table 1](#molecules-22-01825-t001){ref-type="table"}) combined with DEPT 135 spectrum displayed 22 resonances for a carbonyl carbon (*δ*~C~ 188.3), 12 aromatic carbons (*δ*~C~ 164.1, 163.3, 161.7, 157.7, 129.1, 128.3, 128.3, 115.2, 115.2, 106.1, 96.1, and 94.0), one oxymethine carbon (*δ*~C~ 78.3), one methoxyl group (*δ*~C~ 55.9), one methylene carbon (*δ*~C~ 44.7), and a [d]{.smallcaps}-glucosyl moiety (*δ*~C~ 99.7, 77.2, 76.5, 73.1, 69.7, and 60.7), which was supported by the result of the acid hydrolysis and HPLC analysis. Based on the above evidence, the aglycone of **1** was identified as flavanone. Additionally, the configuration of the anomeric carbon was deduced to be *β* based on the coupling constant of the anomeric proton (H-1′′ 7.8 Hz). The glucosidic linkage was established by the HMBC correlation ([Figure 2](#molecules-22-01825-f002){ref-type="fig"}) between H-1′′ (*δ*~H~ 4.99) and C-7 (*δ*~C~ 163.3), indicating that the glucosyl moiety was attached to C-7. Moreover, the methoxyl group was located at C-5 by the HMBC correlation from 5-OCH~3~ (*δ*~H~ 3.78) to C-5 (*δ*~C~ 161.7). With the aid of ^1^H-^1^H COSY, HSQC, and HMBC correlations allowed the established the planar structure and assigned all the ^1^H- and ^13^C-NMR signals of **1**, which was isolated from *Prunus cerasoides* and named puddumin A \[[@B10-molecules-22-01825]\]. However, only incomplete 1D-NMR data of **1** was given in the literature 10, which was also differ greatly from our data ([Table 1](#molecules-22-01825-t001){ref-type="table"}). The electronic circular dichroism (CD) spectrum of **1** ([Figure 3](#molecules-22-01825-f003){ref-type="fig"}) showed a negative Cotton effect at 282 nm (π→π^\*^ electronic transition) and a positive Cotton effect at 338 nm (n→π^\*^ electronic transition), suggesting that the absolute configuration at C-2 was *S* \[[@B9-molecules-22-01825],[@B11-molecules-22-01825]\]. Thus, the structure of **1** was fully elucidated, and it was named hostaflavanone A.

Compound **2** was isolated as a yellow oil, had a molecular formula of C~15~H~22~O~7~ on the basis of the HR-ESI-MS (*m/z* 315.14283, calcd. 315.14383 \[M + H\]^+^). The UV absorption bands at λ~max~ 224 and 274 nm. The ^1^H-NMR spectrum of **2** ([Table 2](#molecules-22-01825-t002){ref-type="table"}) exhibited an AAʹXXʹ coupling system at *δ*~H~ 7.16--7.26 (5H, m), one methxyl at *δ*~H~ 1.16 (3H, d, *J* = 6.3 Hz). The ^13^C-NMR spectrum of **2** ([Table 2](#molecules-22-01825-t002){ref-type="table"}) displayed 15 resonances for six aromatic carbons (*δ*~C~ 140.1, 129.3, 129.3, 127.9, 127.9, and 125.6), two oxymethine carbons (*δ*~C~ 78.6 and 73.7), one methxyl group (*δ*~C~ 16.5), and a glucosyl moiety (*δ*~C~ 102.9, 76.8, 76.4, 73.5, 70.1, and 61.0). The ^1^H and ^13^C-NMR spectra were similar to those of the known compound **3** \[[@B12-molecules-22-01825]\], expect for the presence an additional glucosyl moiety signals. The major differences in the chemical shifts for C-1 (ΔC +2.5), C-2 (ΔC +4.3), and C-3 (ΔC -2.6) were ascribed to glycosylation, suggesting that the glucosyl moiety was located at C-2. Moreover, the configuration of the anomeric carbon was deduced to be *β* based on the coupling constant of the anomeric proton (H-1′′, 7.8 Hz). The small coupling constant ^3^*J*~1,2~ (5.1 Hz) of **2** and **3** ([Table 2](#molecules-22-01825-t002){ref-type="table"}) indicated that **2** and **3** were in the *anti*-configuration. According to the literatures, the *anti*-phenylpropane-1,2-diol displayed smaller coupling constants of ^3^*J*~1,2~ (4.4--5.4 Hz) than *syn*-phenylpropane-1,2-diol (^3^*J*~1,2~ 7--8 Hz) \[[@B12-molecules-22-01825],[@B13-molecules-22-01825],[@B14-molecules-22-01825],[@B15-molecules-22-01825],[@B16-molecules-22-01825],[@B17-molecules-22-01825],[@B18-molecules-22-01825]\]. Due to the shortage of the sample, the two-dimensional (2D)-NMR experiments were not carried out. On the basis of the above evidence, the planar structure of **2** was deduced as *anti*-1-phenylpropane-1,2-diol-2-*O*-β-[d]{.smallcaps}-glucopyranoside.

By comparison of the NMR and MS data with those reported, compounds **3**--**8** isolated from the flower of *H. plantaginea* were identified as *anti*-1-phenylpropane-1,2-diol (**3**) \[[@B12-molecules-22-01825]\], phenethyl-*O*-β-[d]{.smallcaps}-glucopyranoside (**4**) \[[@B19-molecules-22-01825]\], phenethanol-β-gentiobioside (**5**) \[[@B20-molecules-22-01825]\], phenethyl-*O*-rutinoside (**6**) \[[@B21-molecules-22-01825]\], (1*S*,3*S*)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (**7**) \[[@B22-molecules-22-01825]\], and (1*R*,3*S*)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (**8**) \[[@B22-molecules-22-01825]\], respectively.

2.2. Biological Activities {#sec2dot2-molecules-22-01825}
--------------------------

Compounds **1** and **4**--**6** exhibited moderate activity to that of the standard reference drug, and were tested for their inhibitory activity against ovine COX-1 and COX-2 ([Table 3](#molecules-22-01825-t003){ref-type="table"}), with IC~50~ values of 15.5--41.2 and 31.7--45.4 μM, while the IC~50~ values of the positive control celecoxib were 9.0 and 1.0 μM, respectively. While compounds **1** and **4** were more active against COX 1 (SI values \<\<1), compounds **5** and **6** were about equally potent against both COX enzymes with SI values of about 1.

The antioxidant activity of compounds **1**, and **4**--**6** was measured by the 1,1-diphenyl-2-picrylhydrazyl (DPPH) method and the results are summarized in [Table 3](#molecules-22-01825-t003){ref-type="table"}. Only compound **1** exhibited moderate antioxidant activity, with an IC~50~ value of 83.2 μM, while **4**--**6** showed insignificant activity with IC~50~ values of 282, 257, and 275 μM, respectively. The IC~50~ value of the positive control [l]{.smallcaps}-ascorbic acid was 33.9 μM. These compounds may thus, possibly together with further constituents, contribute to the biological activity of *H. plantaginea*.

2.3. Chemotaxonomic Significance {#sec2dot3-molecules-22-01825}
--------------------------------

In our present study, eight compounds including one flavanone (**1**), two phenylpropanoids (**2** and **3**), three phenethanols (**4**--**6**), and two β-carboline alkaloids (**7** and **8**) were isolated from the flowers of *H. plantaginea*. Hostaflavanone A (**1**) and *anti*-1-phenylpropane-1,2-diol-2-*O*-β-[d]{.smallcaps}-glucopyranoside (**2**) were identified as two new ones, and this is the first report of compounds **3**, and **5**--**8** from the Liliaceae family. Additionally, the structure types of flavanone and β-carboline alkaloid from Liliaceae family for the first time.

The phenylpropanoids have been previously isolated from the *Hosta* species, including *trans*-*p*-hydroxy-cinnamic acid from *H. ventricosa* \[[@B23-molecules-22-01825]\], *p*-coumaramide, *trans*-*N*-*p*-coumaroyltyramine, and *cis*-*N*-coumaroyltyramine from *H. longipes* \[[@B24-molecules-22-01825]\], feruloyltyramine, and lyciumide A from *H. ensata* \[[@B25-molecules-22-01825]\]. In addition, the phenethanols **4** and α-hydroxyacetovanillone were isolated from *H. plantaginea* and *H. ventricosa* \[[@B23-molecules-22-01825]\], respectively. Thus, compounds **2**--**6** from *H. plantaginea*, suggesting that their occurrence could be used to verify the chemotaxonomic relationship of *H. plantaginea* and other species of *Hosta*, and also might sever as valuable chemotaxonomic makers for the identification of *H. plantaginea*. Further comprehensive phytochemical investigations involving an expand series of compounds could help define the chemotaxonomic significance of species belonging to genus *Hosta*.

3. Experimental Section {#sec3-molecules-22-01825}
=======================

3.1. General Procedures {#sec3dot1-molecules-22-01825}
-----------------------

Optical rotations were measured using a JASCO P-1020 polarimeter (JASCO Corporation, Tokyo, Japan). The UV spectra were recorded in CH~3~OH using a JASCO V-550 UV-VIS spectrophotometer (JASCO Corporation, Tokyo, Japan). ^1^H (600 MHz), ^13^C (150 MHz), DEPT 135 (150 MHz), and 2D (^1^H-^1^H COSY, HSQC, and HMBC) NMR spectra were recorded on a Bruker AV 600 spectrometer (Bruker Corporation, Fallanden, Switzerland). HR-ESI-MS was measured on a Waters Synapt G2 TOF mass spectrometer (Waters Corporation, Manchester, UK). Column chromatographies (CCs) were carried out on silica gel (200--300 mesh, Marine Chemical Group Corporation, Qingdao, China) and ODS (60--80 µm, YMC, Tokyo, Japan). Silica gel GF~254~ (Marine Chemical Group Corporation, Qingdao, China) was used for analytical TLC. 2,2-Di-phenyl-1-picrylhydrazyl (DPPH) (Sigma Corporation, Ronkonkoma, New York, NY, USA), [l]{.smallcaps}-cysteine methyl ester and *o*-tolyl isothiocyanate (Meilun Biotech. Co. Ltd., Dalian, China), [d]{.smallcaps}-glucose, and [l]{.smallcaps}-glucose (Energy Chemical, Shanghai, China) were used. COX inhibitor screening assay kit was purchased from Cayman Chemical Company (Ann Arbor, MI, USA). The analytical HPLC was performed on a Shimadzu HPLC system equipped with an LC-20AB pump, and a SPD-20A diode array detector (Shimadzu, Kyoto, Japan), using a Phenomenex Gemini C18 column (5 μm, 4.6 mm × 250 mm, Phenomenex Inc., Los Angeles, CA, USA). The preparative HPLC was performed on a Shimadzu LC-6AD system equipped with an LC-6AD pump and an SPD-M20A detector (Shimadzu, Kyoto, Japan), using an RP-18 column (5 μm, 21.2 × 250 mm, Gemini, Phenomenex Inc., Los Angeles, CA, USA; detector set at 220 and 254 nm).

3.2. Plant Materials {#sec3dot2-molecules-22-01825}
--------------------

The flowers of *Hosta plantaginea* (Lam.) Aschers were collected in Shanquan town, Nanchuan district, Chongqing, People's Republic of China, in September 2014, and were identified by one of authors (Guo-yue Zhong). A voucher specimen (no. YZH201409) was deposited at the Research Center of Natural Resources of Chinese Medicinal Materials and Ethnic Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

3.3. Extraction and Isolation {#sec3dot3-molecules-22-01825}
-----------------------------

The air-dried and powdered flowers of *H. plantaginea* (16.5 kg) were extracted three times with 80% EtOH (40 L) by maceration at room temperature for three days. After filtration, combination, and solvent evaporation the residue (6.60 kg) was dissolved in water and successively partitioned with petroleum ether, ethyl acetate, and *n*-BuOH to afford petroleum ether (A, 363 g), ethyl acetate (B, 127 g), *n*-BuOH (C, 804 g), and water (5.27 kg) extracts, respectively. The *n*-BuOH extract (760 g) was subjected to HP20 macroporous adsorption resin column chromatography (CC) eluting with H~2~O, 20%, 50%, and 95% aqueous EtOH to give four fractions, c1, c2, c3, and c4, respectively. Fr. c2 (32.8 g) was subjected to MCI CC using a EtOH/H~2~O gradient elution (10%, 20%, 30%, and 95%) to give four fractions (c21 to c2d). The subfraction c2c (6.02 g) was applied to silica gel CC eluting with dichloromethane--CH~3~OH (5:1, 3:1, 1;1, 0:100, *v*/*v*) to afford four subfractions (c2c1--c2c4). c2c2 (1.04 g) was purified by pre-HPLC eluting with CH~3~OH/H~2~O (*v*/*v*, 35:65, flow rate: 10 mL/min) to afford compound **1** (53.7 mg, t~R~ 22.7 min). The subfraction c2b (15.1 g) was applied to polyamide CC using a EtOH/H~2~O gradient elution (10%, 20%, and 95%) to afford five subfractions (c2b1--c2b5). The subfraction c2b1 (7.12 g) was applied to silica gel CC eluting with dichloromethane--CH~3~OH (10:1, 5:1, 1:5, *v*/*v*) to afford four subfractions (c2b11--c2b14). c2b11 (1.81 g) was purified by pre-HPLC eluting with CH~3~CN/H~2~O (*v*/*v*, 20:80, flow rate: 2 mL/min) to afford compounds **2** (1.0 mg, t~R~ 15.0 min), **3** (0.7 mg, t~R~ 25.3 min), and **4** (1.45 g, t~R~ 17.2 min). c2b12 (1.19 g) was purified by pre-HPLC eluting with CH~3~OH/H~2~O (*v*/*v*, 30:70, flow rate: 10 mL/min) to afford compound6 **6** (1.10 g, t~R~ 31.0 min). The subfraction c2a (8.05 g) was applied to silica gel CC eluting with dichloromethane/CH~3~OH (1:1, 1:3, 1:10, *v*/*v*) to afford three subfractions (c2a1--c2a3). c2a1 (3.89 g) was subjected to Sephadex LH-20 CC eluting with CH~3~OH to afford three subfractions (c2a11--c2a13). c2a12 (2.59 g) was purified by pre-HPLC eluting with CH~3~OH/H~2~O (*v*/*v*, 25:75, flow rate: 10 mL/min) to afford compounds **5** (329 mg, t~R~ 32.8 min), **7** (1.9 mg, t~R~ 23.2 min), and **8** (1.4 mg, t~R~ 27.3 min).

3.4. Acid Hydrolysis and HPLC Analysis {#sec3dot4-molecules-22-01825}
--------------------------------------

The absolute configurations of the sugar moieties in the structures were determined by the previously described method with minor modifications \[[@B9-molecules-22-01825]\]. Compound **1** (3 mg) was hydrolyzed with 2 mL of 2 M HCl for 3 h at 90 °C. The mixture was evaporated to dryness in vacuo, and the residue was dissolved in H~2~O and extracted with CHCl~3~. After the aqueous layer was dried in vacuo, the residue was dissolved in pyridine (1 mL) containing [l]{.smallcaps}-cysteine methyl ester (1 mg) and heated at 60 °C for 1 h. *o*-Tolyl isothiocyanate (5 μL) was added, and the mixture was heated at 60 °C for 1 h and directly analyzed by HPLC. Analytical HPLC was performed on a reversed-phase C18 column (5 μm, 4.60 × 250 mm; Intertsutain, Shimadzu) at 30 °C with isocratic elution using 25% CH~3~CN containing 0.1% formic acid for 40 min at a flow rate 0.8 mL/min. The peaks were detected with a UV detector at 250 nm. The standard monosaccharides, [d]{.smallcaps}-glucose, and [l]{.smallcaps}-glucose, were subjected to the same process.

3.5. In Vitro COX-1 and COX-2 Inhibitory Assay {#sec3dot5-molecules-22-01825}
----------------------------------------------

Inhibitory activities of the compounds towards COX-1 and COX-2 activity was determined using colorimetric COX (ovine) inhibitor screening assay kit (Cayman, no. 760111) following the manufacturer's instructions, using celecoxib as a positive control \[[@B26-molecules-22-01825]\]. The 50% inhibitory concentration (IC~50~) values were calculated from the concentration-inhibition response curve.

3.6. Antioxidant Assay {#sec3dot6-molecules-22-01825}
----------------------

DPPH radical-scavenging activity of the sample was measured as previously described with minor modifications \[[@B27-molecules-22-01825]\]. In a 96-well microplate, 150 μL of DPPH solution (200 μM) was added to 50 μL of the test sample in methanol at different concentrations. The OD values of the reaction mixtures was recorded at 517 nm using a Multiskan Go (Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 40 min at 30 °C. The DPPH radical scavenging activity was calculated by the following equation: DPPH scavenging activity % = (A~sample~ -- A~blank~)/A~control~ × 100, where A~sample~ represents the absorbance of sample and DPPH, A~blank~ represents the absorbance of sample and CH~3~OH, A~control~ represents the absorbance of DPPH and CH~3~OH. IC~50~ value was calculated as the concentration required to scavenge 50% DPPH free radicals and was obtained by plotting the DPPH-scavenging percentage of each sample against the sample concentration. [l]{.smallcaps}-ascorbic acid was used as the positive control in this experiment. All tests were run in triplicate, and values obtained from experiments were averaged.

4. Conclusions {#sec4-molecules-22-01825}
==============

In summary, one new flavanone (**1**) and one new phenylpropanoid (**2**), together with six known ones, one phenylpropanoid (**3**), three phenethanols (**4**--**6**), and two β-carboline alkaloids (**7** and **8**), were isolated from the flowers of *H. plantaginea*. This is the first report of compounds **3** and **5**--**8** from the Liliaceae family. Additionally, the structure types of flavanone and β-carboline alkaloid from the Liliaceae family for the first time. Moreover, compounds **2**--**6** from *H. plantaginea* suggest that their occurrence could be used to verify the chemotaxonomic relationship of *H. plantaginea* and other species of *Hosta*, and also might serve as valuable chemotaxonomic makers for the identification of *H. plantaginea*. The cyclooxygenases' (COX-1 and COX-2) inhibition and antioxidant activities of compounds **1** and **4**--**6** were investigated, and they showed moderate cyclooxygenase inhibition activities. Moreover, only compound **1** exhibited moderate antioxidant activity, with an IC~50~ value of 83.2 μM, while **4**--**6** showed insignificant activity with IC~50~ values of 282, 257, and 275 μM, respectively. These compounds may, possibly together with further constituents, contribute to the biological activity of *H. plantaginea*.
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molecules-22-01825-t001_Table 1

###### 

^13^C- and ^1^H-NMR data for compounds **1** and puddumin A in DMSO-*d*~6~ (*δ* in ppm).

  Position                        1              Puddumin A                               
  ------------------------------- -------------- -------------------------------- ------- -----------------------
  2                               78.3           5.40 (1H, m)                     78.3    6.15 (1H, s)
  3                               44.7           3.07 (1H, dd, *J* = 16.3/12.8)   44.5    3.30 (1H, d, *J* = 2)
  2.57 (1H, dd, *J* = 16.3/2.5)   2.70 (1H, s)                                            
  4                               188.3          \- ^a^                           192.4   \- ^a^
  5                               161.7          \- ^a^                           159.9   \- ^a^
  6                               94.0           6.28 (1H, d, *J* = 2.5)          93.7    6.40 (1H, d, *J* = 2)
  7                               163.3          \- ^a^                           165.6   \- ^a^
  8                               96.1           6.24 (1H, d, *J* = 2.5)          95.1    6.78 (1H, d, *J* = 2)
  9                               164.1          \- ^a^                           165.1   \- ^a^
  10                              106.1          \- ^a^                           106.5   \- ^a^
  1′                              129.1          \- ^a^                           126.0   \- ^a^
  2′, 6′                          128.3          7.30 (2H, d, *J* = 8.4)          130.8   7.65 (2H, d, *J* = 9)
  3′, 5′                          115.2          6.79 (2H, d, *J* = 8.4)          115.9   6.83 (2H, d, *J* = 9)
  4′                              157.7          \- ^a^                           159.6   \- ^a^
  1′′                             99.7           4.99 (1H, d, *J* = 7.8)          100.3   \- ^b^
  2′′                             73.1           3.23 (1H, m)                     73.3    \- ^b^
  3′′                             76.5           3.28 (1H, m)                     76.8    \- ^b^
  4′′                             69.7           3.14 (1H, m)                     69.6    \- ^b^
  5˝                              77.2           3.39 (1H, m)                     77.5    \- ^b^
  6′′                             60.7           3.68 (1H, m)                     60.6    
  3.43 (1H, m)                    ^b^                                                     
  5-OCH~3~                        55.9           3.78 (3H, s)                     55.5    3.80 (3H, s)

^a^ no signal; ^b^ not assigned.

molecules-22-01825-t002_Table 2

###### 

^13^C- and ^1^H-NMR data for compounds **2** and **3** in DMSO-*d*~6~ (*δ* in ppm).

  Position   3        2                                 
  ---------- -------- ------------------------- ------- -------------------------
  1          76.1     4.48 (1H, d, *J* = 5.1)   78.6    4.43 (1H, d, *J* = 5.1)
  2          69.4     4.41 (1H, m)              73.7    4.40 (1H, m)
  3          19.1     1.08 (3H, d, *J* = 6.0)   16.5    1.16 (3H, d, *J* = 6.3)
  1′         140.3                              140.1   
  2′, 6′     127.8    7.15--7.26 (5H, m)        127.9   7.16-7.26 (5H, m)
  3′, 5′     129.3    7.15--7.26 (5H, m)        129.3   7.16-7.26 (5H, m)
  4′         125.5    7.15--7.26 (5H, m)        125.6   7.16-7.26 (5H, m)
  1′′        \- ^b^   \- ^b^                    102.9   4.23 (1H, d, *J* = 7.8)
  2′′        \- ^b^   \- ^b^                    73.5    \- ^a^
  3′′        \- ^b^   \- ^b^                    76.4    \- ^a^
  4′′        \- ^b^   \- ^b^                    70.1    \- ^a^
  5′′        \- ^b^   \- ^b^                    76.8    \- ^a^
  6′′        \- ^b^   \- ^b^                    61.0    \- ^a^

^a^ not assigned; ^b^ no signal.

molecules-22-01825-t003_Table 3

###### 

In vitro COX-1/COX-2 inhibition and antioxidant activities of isolated compounds.

  Compounds                       IC~50~ (μM)   SI ^d^                    
  ------------------------------- ------------- ------------ ------------ --------
  **1**                           21.6 ± 1.2    45.4 ± 3.3   83.2 ± 3.0   0.48
  **4**                           15.5 ± 0.6    38.2 ± 3.9   282 ± 5.2    0.41
  **5**                           38.4 ± 1.3    31.7 ± 2.9   257 ± 13.8   1.16
  **6**                           41.2 ± 1.5    35.4 ± 1.6   275 ± 14.8   1.21
  celecoxib                       9.0 ± 0.6     1.0 ± 0.1    \- ^c^       9.00
  [l]{.smallcaps}-ascorbic acid   \- ^c^        \- ^c^       33.9 ± 1.1   \- ^c^

^a^ Meaning the 50% inhibition concentration of isolated compounds calculated from regression using five different concentrations (100, 50, 25, 12.5, 6.25 μM); ^b^ Meaning the 50% inhibition concentration of isolated compounds calculated from regression using five different concentrations (500, 200, 100, 50, 25 μM); ^c^ Not determined; ^d^ SI (Selectivity Index) = IC~50~ (COX-1)/IC~50~ (COX-2).
